We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Automated AI-Powered Microscope Accurately Identifies Malaria Parasites in Blood Samples

By LabMedica International staff writers
Posted on 11 Aug 2023

Every year, over 200 million individuals contract malaria, with more than half a million of these cases resulting in fatalities. More...

The World Health Organization advocates for the use of parasite-based diagnosis prior to commencing treatment for the infectious disease caused by Plasmodium parasites. Various diagnostic techniques are available, including conventional light microscopy, rapid diagnostic tests, and PCR. Nevertheless, the established benchmark for malaria diagnosis is manual light microscopy, where a specialist examines blood samples under a microscope to verify the presence of malaria parasites. However, the result accuracy is heavily dependent on the expertise of the microscopist and can be affected by fatigue caused by workloads among the professionals conducting the tests.

Due to the demanding nature of traditional diagnosis and the high workload, an international team of researchers undertook an investigation into the feasibility of employing a novel system that combines an automated scanning microscope with artificial intelligence (AI) for clinical diagnosis. The results indicated that this system identified malaria parasites with almost the same accuracy as experienced microscopists following standard diagnostic procedures. This advancement holds the potential to ease the burden of microscopists and increase the manageable patient caseload.

Researchers at The Hospital for Tropical Diseases at UCLH (London, UK) tested a fully automated malaria diagnostic system comprising both hardware and software components. The automated microscopy platform scans blood samples, and algorithms for malaria detection process the images to detect the presence and quantity of parasites. The researchers analyzed more than 1,200 blood samples from travelers who had returned to the UK from regions where malaria is prevalent. The study evaluated the accuracy of the AI-microscope system in a true clinical setting under ideal conditions.

The researchers compared the results obtained from both manual light microscopy and the AI-microscope system. Manually, 113 samples were identified as having malaria parasites, whereas the AI system accurately detected 99 positive samples, resulting in an 88% accuracy rate. Despite this commendable accuracy rate, the automated system also produced false positives, indicating 122 samples as positive when they were not, potentially leading to unnecessary administration of anti-malarial drugs to patients.

“At an 88% diagnostic accuracy rate relative to microscopists, the AI system identified malaria parasites almost, though not quite, as well as experts,” said Dr. Roxanne Rees-Channer, a researcher at The Hospital for Tropical Diseases at UCLH. “This level of performance in a clinical setting is a major achievement for AI algorithms targeting malaria. It indicates that the system can indeed be a clinically useful tool for malaria diagnosis in appropriate settings.”

Related Links:
UCLH 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image Credit: 123RF

Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

Inherited cancer risk can affect children, adolescents and young adults, but it may not always be apparent from tumor type or family history alone. Some cancer syndromes require specialized expertise and... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.